|
|
|
|
Technology |
|
|
|
|
|
Adhaere has developed an innovative approach for targeting extracellular adhesion receptors on leukocytes for the discovery and development of novel anti-inflammatory drugs. Adhaere's discovery platform technology uses a unique and novel cell-adhesion based high-throughput screening assay for rapid identification and optimization of novel therapeutics and agents against a majority of cell adhesion receptors. |
|
|
|
|
|
|
News and Publications |
|
|
|
|
|
Small molecule mediated activation of integrin CD11b/CD18 reduces inflammatory disease.
Science Signaling, 2011. |
|
|
view more... |
|
|
